1. Home
  2. PSN vs TECH Comparison

PSN vs TECH Comparison

Compare PSN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parsons Corporation

PSN

Parsons Corporation

HOLD

Current Price

$62.70

Market Cap

9.2B

Sector

Technology

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$59.09

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSN
TECH
Founded
1944
1976
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
9.2B
IPO Year
2019
1989

Fundamental Metrics

Financial Performance
Metric
PSN
TECH
Price
$62.70
$59.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
14
Target Price
$85.29
$71.23
AVG Volume (30 Days)
2.2M
1.6M
Earning Date
11-05-2025
02-04-2026
Dividend Yield
N/A
0.54%
EPS Growth
7.02
N/A
EPS
2.17
0.49
Revenue
$6,494,748,000.00
$1,216,732,000.00
Revenue This Year
N/A
$2.33
Revenue Next Year
$4.29
$7.05
P/E Ratio
$28.83
$121.67
Revenue Growth
N/A
3.85
52 Week Low
$54.56
$46.01
52 Week High
$97.91
$79.28

Technical Indicators

Market Signals
Indicator
PSN
TECH
Relative Strength Index (RSI) 31.18 46.70
Support Level $62.22 $56.84
Resistance Level $64.79 $59.58
Average True Range (ATR) 2.13 1.72
MACD 0.09 -0.07
Stochastic Oscillator 36.62 48.24

Price Performance

Historical Comparison
PSN
TECH

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: